In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Fisher Scientific sells $300mm of convertible notes

Executive Summary

Life sciences and diagnostics company Fisher Scientific sold $300mm of convertible senior subordinated notes due 2024. The notes carry an interest rate of 3.25% and convert into common stock at a price of $80.40 per share.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies

UsernamePublicRestriction

Register